|
CEST (UTC +2 Berlin) 11:00–12:00 hours
|
|
INDUSTRY-SPONSORED SYMPOSIUM *
|
| |
|
| 11:00-12:00 |
Industry-Sponsored Symposium by AstraZeneca
|
|
| 12:00-13:00 |
Lunch
|
|
| *This non-accredited industry-sponsored symposium is not part of the accredited CME programme. |
|
add to calendar |
CEST (UTC +2 Berlin) 13:00 – 15:00 hours
PST (UTC +8 Manila) 19:00 – 21:00 hours
EDT (UTC -4 New York) 07:00 AM – 09:00 AM
|
|
OPENING SESSION (HYBRID)
|
| Moderators |
Maria Dall’Era (USA) & Thomas Dörner (Germany)
|
| 13:00 |
Opening Remarks (10 mins) |
Thomas Dörner (Germany)
|
| |
Recent Advances in the Pathogenesis and Management of Lupus Nephritis
|
|
| 13:10 |
2024 ACR lupus nephritis guidelines (20 mins)
|
Maria Dall’Era (USA)
|
| 13:30 |
EULAR recommendations for lupus nephritis (20 mins)
|
Antonis Fanouriakis (Greece)
|
| 13:50 |
Update on urinary biomarkers in lupus nephritis (20 mins)
|
Andrea Fava (USA)
|
| 14:10 |
Nephroprotective therapies: Which one and when to start? (SGLT2i, GLP-1, MRA) (20 mins)
|
Eva Schrezenmeier (Germany)
|
| 14:30 |
Q&A & Panel Discussion (30 mins)
|
|
| 15:00-15:30 |
Break and Poster Viewing
|
|
|
add to calendar |
|
CEST (UTC +2 Berlin) 15:30 – 17:00
|
|
PLENARY I: THE ULTIMATE GOALS "OUTCOME, OUTCOME, OUTCOME...!"
|
| Moderators |
Murray Urowitz (Canada) & David Isenberg (UK)
|
| 15:30 |
How are we doing in controlling SLE activity? (20 mins)
|
Sandra Navarra (Philippines)
|
| 15:50 |
Belimumab versus anifrolumab in non-renal SLE: Which drug for which patient? (20 mins)
|
Andrea Doria (Italy)
|
| 16:10 |
Cardiovascular outcomes in SLE: A cardio-rheumatologist’s perspective (20 mins)
|
Brittany Weber (USA) - Virtual
|
| 16:30-17:00 |
Q&A & Panel Discussion (30 mins)
|
|
|
add to calendar |
|
CEST (UTC +2 Berlin) 17:00 – 18:30
|
|
KEYNOTES: SLE IN THE 21ST CENTURY
|
| Moderators |
Bernardo Pons Estel & Maria Dall’Era (USA)
|
| 17:00 |
Update on diet and the microbiome in SLE (30 mins)
|
Gregg Silverman (USA)
|
|
Q&A & Panel Discussion (15 minutes)
|
|
| 17:45 |
Emerging insights: Brain-reactive antibodies and
neuropsychiatric SLE versus autoimmune
encephalomyelitis (30 mins)
|
Thomas Skripuletz (Germany)
|
| |
Q&A & Panel Discussion (15 minutes)
|
|
| 18:30-20:00 |
Networking Walking Dinner and Poster Viewing
|
|
|
add to calendar |
|
CEST (UTC +2 Berlin) 07:30 - 08:30 hours
|
|
INDUSTRY-SPONSORED SYMPOSIUM *
|
| |
|
| 07:30-08:30 |
Industry-Sponsored Symposium by Bristol Myers Squibb
|
|
| 08:30-09:00 |
Break
|
|
| *This non-accredited industry-sponsored symposium is not part of the accredited CME programme. |
|
add to calendar |
|
CEST (UTC +2 Berlin) 09:00 – 10:30
|
|
INTERACTIVE CASE STUDY WORKSHOPS
|
| Moderator |
Zahir Amoura (France)
|
| 9:00 |
Managing lupus and cardiovascular disease
(90 mins)
|
Murray Urowitz (Canada) &
Mike Nurmohamed (Netherlands)
|
| Moderator |
Bernando Pons Estel (Argentina)
|
| 9:00 |
Managing haematologic manifestations in SLE
(90 mins)
|
David Isenberg (UK) &
George Bertsias (Greece)
|
| Moderator |
Angela Tincani (Italy)
|
| 9:00 |
Family planning and pregnancy in SLE
(90 mins)
|
Ian Giles (UK) &
Ana Luisa Stefanski (Germany)
|
| Moderator |
Andrea Doria (Italy)
|
| 9:00 |
Managing lupus skin manifestations
(90 mins)
|
Annegret Kuhn (Germany) &
Victoria Werth (USA)
|
| Moderator |
Richard Furie (USA)
|
| 9:00 |
Assessing and managing lupus arthritis
(90 mins)
|
Anca Askanase (USA) &
Alexandre Voskuyl (Netherlands)
|
| 10:30-11:00 |
Break and Poster Viewing
|
|
|
add to calendar |
CEST (UTC +2 Berlin) 11:00 – 13:00 hours
PST (UTC +8 Manila) 17:00 – 19:00 hours
EDT (UTC -4 New York) 05:00 AM – 07:00 AM
|
|
PRIME TIME SESSION: (HYBRID)
|
| NEW GOALS IN SLE: WHAT DOES REMISSION LOOK LIKE? |
| Moderators |
Richard Furie (USA) &
Andrea Doria (Italy)
|
| 11:00 |
LLDAS and DORIS remission: redefined or refined?:
The rheumatologist’s perspective (25 mins)
|
Ronald van Vollenhoven (Netherlands)
|
| 11:25 |
Remission in lupus nephritis: The nephrologist’s perspective (25 minutes)
|
Onno Teng (Netherlands)
|
| 11:50 |
Lupus skin and remission: The dermatologist’s perspective (25 mins)
|
Victoria Werth (USA)
|
| 12:10 |
Lupus arthritis: Adequate joint assessment in SLE trials (25 mins)
|
Ed Vital (UK)
|
| 13:35 |
Q&A & Panel Discussion (25 mins)
|
|
| 13:00-14:00 |
Lunch and Poster Viewing
|
|
|
add to calendar |
|
CEST (UTC +2 Berlin) 14:00 – 14:30
|
|
KEYNOTE: EMERGING PATHOGENIC INSIGHTS
|
| Moderators |
Sandra Navarra &Maria Dall’Era (USA)
|
| 14:00 |
Recent insights from innate immunity: Implications for SLE (25 mins)
|
Eicke Latz (Germany)
|
|
Q&A (5 minutes)
|
|
|
add to calendar |
|
CEST (UTC +2 Berlin) 14:30 – 16:00
|
|
PLENARY II: EMERGING TREATMENT CONCEPTS
|
| Moderators |
David Isenberg (UK) & Bernardo Pons Estel (Argentina)
|
| 14:30 |
Mechanisms of glucocorticoids revisited: The dose makes the poison (?) (25 mins)
|
Gerhard Krönke (Germany)
|
| 14:55 |
Co-stimulation blockade of CD40/CD40L in SLE and beyond (25 mins)
|
Zahir Amoura (France)
|
| 15:20 |
News and Views: Exciting new approaches in therapy, double-hit therapies, JAK inhibitors (25 mins)
|
Murray Urowitz (Canada)
|
| 15:45 |
Q&Q & Panel Discussion (15 mins)
|
|
| 16:00-16:30 |
Break and Poster Viewing
|
|
|
add to calendar |
|
CEST (UTC +2 Berlin) 16:30 – 18:00
|
|
INTERACTIVE CASE STUDY WORKSHOPS
|
| Moderator |
Zahir Amoura (France)
|
| 16:30 |
Managing lupus and cardiovascular disease
(90 mins)
|
Murray Urowitz (Canada) &
Mike Nurmohamed (Netherlands)
|
| Moderator |
Bernando Pons Estel (Argentina)
|
| 16:30 |
Managing haematologic manifestations in SLE
(90 mins)
|
David Isenberg (UK) &
George Bertsias (Greece)
|
| Moderator |
Angela Tincani (Italy)
|
| 16:30 |
Family planning and pregnancy in SLE
(90 mins)
|
Ian Giles (UK) &
Ana Luisa Stefanski (Germany)
|
| Moderator |
Andrea Doria (Italy)
|
| 16:30 |
Managing lupus skin manifestations
(90 mins)
|
Annegret Kuhn (Germany) &
Victoria Werth (USA)
|
| Moderator |
Richard Furie (USA)
|
| 16:30 |
Assessing and managing lupus arthritis
(90 mins)
|
Anca Askanase (USA) &
Alexandre Voskuyl (Netherlands)
|
| 18:00 |
Session Close and Poster Viewing
|
|
|
add to calendar |
|
CEST (UTC +2 Berlin) 07:30 – 08:30 hours
|
|
INDUSTRY-SPONSORED SYMPOSIUM *
|
| |
|
| 07:30-08:30 |
Industry-Sponsored Symposium by GSK
|
|
| 08:30-09:00 |
Break
|
|
| *This non-accredited industry-sponsored symposium is not part of the accredited CME programme. |
|
add to calendar |
|
CEST (UTC +2 Berlin) 09:00 – 10:30
|
|
THIEVES' MARKET AND POSTER PRESENTATIONS*
|
| Moderators |
Zahir Amoura (France) & Ricard Cervera (Spain)
|
| 09:00 |
Thieves Market: Case 1 (20 Mins inc. Q&A)
|
All presenters will be selected from submissions
|
| 09:20 |
Thieves Market: Case 2 (20 Mins inc. Q&A)
|
All presenters will be selected from submissions
|
| 09:40 |
Poster 1 (10 Mins inc. Q&A)
|
All presenters will be selected from submissions
|
| 09:50 |
Poster 2 (10 Mins inc. Q&A)
|
All presenters will be selected from submissions
|
| 10:00 |
Poster 3 (10 Mins inc. Q&A)
|
All presenters will be selected from submissions
|
| 10:10 |
Poster 4 (10 Mins inc. Q&A)
|
All presenters will be selected from submissions
|
| 10:20 |
Thieves Market and Poster Awards (10 Mins)
|
All
|
| 10:30-11:00 |
Break and Poster Viewing
|
|
*Thieves’ market and Poster Session are not part of the accredited CME total.
More Posters are available at lupus-academy.org |
|
add to calendar |
CEST (UTC +2 Berlin) 11:00 – 13:00 hours
PST (UTC +8 Manila) 17:00 – 19:00 hours
EDT (UTC -4 New York) 05:00 AM – 07:00 AM
|
|
PLENARY III: B-CELL DEPLETION IN SLE: PAST, PRESENT AND FUTURE (HYBRID)
|
| Moderators |
Thomas Dörner (Germany) & David Isenberg (UK)
|
| 11:00 |
Historical perspectives on B-cell depletion in SLE (25 mins)
|
David Isenberg (Germany)
|
| 11:25 |
Anti-CD20 therapy: Where are we today? (25 mins)
|
Richard Furie (USA)
|
| 11:50 |
T-cell engager experience in SLE (25 mins)
|
Gerhard Krönke (Germany)
|
| 12:15 |
CAR-T: Emerging options (25 mins)
|
Georg Schett (Germany)
|
| 12:40 |
Panel Discussion (20 mins)
|
|
| 13:00 |
Concluding Remarks and Meeting Close
|
|
|
add to calendar |
